A series of two whitepapers produced by ACD/Labs discusses how pharma and biotech organisations can leverage automation and ...

Ecolab Life Sciences has launched Klercide Rapid Sporicide, a new sporicidal disinfectant designed to improve pharmaceutical cleanroom safety and performance while reducing overall production turnover ...

Advancements in genomic research have brought the development of nucleic acid drugs (NADs), which regulate and translate nucleic acid functions. These therapies have demonstrated long-lasting efficacy ...

Abzena, a specialist in end-to-end integrated CDMO of complex biologics and bioconjugates, and Mabqi, a biotechnology company ...

Since then, funding initiatives across the US and Europe have arisen to build research facilities, set up universal standards ...

Working in a cleanroom is like completing a long, detailed puzzle – it requires focus, patience, and stamina. When gloves ...

The reliance on single-use items fosters a linear ‘take-make-dispose’ model, unsustainable in a resource-constrained world.

November 14, 2025, marks the 19th World Diabetes Day, with this year's theme being "Diabetes and Well-being". Aligning with the theme, Insilico Medicine, a clinical-stage biotechnology company, is ...

These disposable transfer pipettes have been developed to meet the demands of various scientific and medical applications. Available in a variety of sizes and styles, they are designed for the ...

Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...

Since Arm’s organs are created from scratch with the purpose of mimicking life-like physiological responses, they bypass the complications and costs that arise from preserving cadavers through ...

New figures from the World Obesity Federation suggest that if current trends continue, 2.7 billion adults worldwide will be overweight by 2025 (1). This is an increase from 2.0 billion in 2014.